biguanides has been researched along with Digestive System Neoplasms in 1 studies
Biguanides: Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES.
biguanides : A class of oral hypoglycemic drugs used for diabetes mellitus or prediabetes treatment. They have a structure based on the 2-carbamimidoylguanidine skeleton.
Digestive System Neoplasms: Tumors or cancer of the DIGESTIVE SYSTEM.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiu, CC | 1 |
| Huang, CC | 1 |
| Chen, YC | 1 |
| Chen, TJ | 1 |
| Liang, Y | 1 |
| Lin, SJ | 1 |
| Chen, JW | 1 |
| Leu, HB | 1 |
| Chan, WL | 1 |
1 other study available for biguanides and Digestive System Neoplasms
| Article | Year |
|---|---|
Increased risk of gastrointestinal malignancy in patients with diabetes mellitus and correlations with anti-diabetes drugs: a nationwide population-based study in Taiwan.
Topics: alpha-Glucosidases; Biguanides; Cohort Studies; Diabetes Mellitus; Digestive System Neoplasms; Human | 2013 |